Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma
4 Visninger
• 07/18/23
0
0
Indlejre
administrator
Abonnenter
Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer